Annual Current Liabilities
$138.85 M
+$42.29 M+43.80%
December 31, 2023
Summary
- As of February 7, 2025, AXSM annual total current liabilities is $138.85 million, with the most recent change of +$42.29 million (+43.80%) on December 31, 2023.
- During the last 3 years, AXSM annual current liabilities has risen by +$115.42 million (+492.43%).
- AXSM annual current liabilities is now at all-time high.
Performance
AXSM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$196.19 M
+$9.62 M+5.15%
September 30, 2024
Summary
- As of February 7, 2025, AXSM quarterly total current liabilities is $196.19 million, with the most recent change of +$9.62 million (+5.15%) on September 30, 2024.
- Over the past year, AXSM quarterly current liabilities has increased by +$57.33 million (+41.29%).
- AXSM quarterly current liabilities is now at all-time high.
Performance
AXSM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AXSM Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.8% | +41.3% |
| 3 y3 years | +492.4% | +694.0% |
| 5 y5 years | +1183.1% | +960.0% |
AXSM Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +502.0% | at high | +750.6% |
| 5 y | 5-year | at high | +502.0% | at high | +864.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Axsome Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $196.19 M(+5.2%) |
| Jun 2024 | - | $186.57 M(+29.5%) |
| Mar 2024 | - | $144.05 M(+3.7%) |
| Dec 2023 | $138.85 M(+43.8%) | $138.85 M(+21.1%) |
| Sep 2023 | - | $114.66 M(-0.3%) |
| Jun 2023 | - | $114.97 M(+14.2%) |
| Mar 2023 | - | $100.65 M(+4.2%) |
| Dec 2022 | $96.56 M(+318.6%) | $96.56 M(+60.2%) |
| Sep 2022 | - | $60.28 M(+41.6%) |
| Jun 2022 | - | $42.57 M(+73.4%) |
| Mar 2022 | - | $24.55 M(+6.4%) |
| Dec 2021 | $23.07 M(-1.6%) | $23.07 M(-6.6%) |
| Sep 2021 | - | $24.71 M(+8.1%) |
| Jun 2021 | - | $22.86 M(+5.4%) |
| Mar 2021 | - | $21.68 M(-7.5%) |
| Dec 2020 | $23.44 M(-4.3%) | $23.44 M(+15.2%) |
| Sep 2020 | - | $20.34 M(-11.6%) |
| Jun 2020 | - | $23.00 M(-11.9%) |
| Mar 2020 | - | $26.10 M(+6.6%) |
| Dec 2019 | $24.49 M | $24.49 M(+32.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $18.51 M(+41.6%) |
| Jun 2019 | - | $13.07 M(+69.5%) |
| Mar 2019 | - | $7.71 M(-28.8%) |
| Dec 2018 | $10.82 M(-11.1%) | $10.82 M(-1.1%) |
| Sep 2018 | - | $10.94 M(+14.9%) |
| Jun 2018 | - | $9.53 M(+1.1%) |
| Mar 2018 | - | $9.42 M(-22.6%) |
| Dec 2017 | $12.18 M(+69.8%) | $12.18 M(+44.9%) |
| Sep 2017 | - | $8.40 M(+2.3%) |
| Jun 2017 | - | $8.21 M(-1.7%) |
| Mar 2017 | - | $8.36 M(+16.5%) |
| Dec 2016 | $7.17 M(+172.5%) | $7.17 M(+6.5%) |
| Sep 2016 | - | $6.74 M(+32.0%) |
| Jun 2016 | - | $5.10 M(+30.4%) |
| Mar 2016 | - | $3.91 M(+48.7%) |
| Dec 2015 | $2.63 M(+170.6%) | $2.63 M(+17.8%) |
| Sep 2015 | - | $2.23 M(+46.1%) |
| Jun 2015 | - | $1.53 M(+57.3%) |
| Dec 2014 | $972.60 K(-76.4%) | $972.60 K |
| Dec 2013 | $4.13 M | - |
FAQ
- What is Axsome Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics annual current liabilities year-on-year change?
- What is Axsome Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly current liabilities year-on-year change?
What is Axsome Therapeutics annual total current liabilities?
The current annual current liabilities of AXSM is $138.85 M
What is the all time high annual current liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total current liabilities is $138.85 M
What is Axsome Therapeutics annual current liabilities year-on-year change?
Over the past year, AXSM annual total current liabilities has changed by +$42.29 M (+43.80%)
What is Axsome Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of AXSM is $196.19 M
What is the all time high quarterly current liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total current liabilities is $196.19 M
What is Axsome Therapeutics quarterly current liabilities year-on-year change?
Over the past year, AXSM quarterly total current liabilities has changed by +$57.33 M (+41.29%)